LETTER TO THE JOURNAL
Ascites of patients with solid tumors shows distinct inflammatory patterns
Julia M. Berger, Martin Korpan, Carina Zierfuss, Katharina Syb?ck, Erwin Tomasich, Andreas Kienzle, Maria Koenig, Markus Kleinberger, Lynn Gottmann, Birgit Fendl, Cihan Ay, Johannes Pammer, Catharina Müller, Rudolf Oehler, Lorenz Balcar, Thomas Reiberger, Elisabeth S. Bergen, Barbara Niederdorfer, Matthias Preusser, Anna S. Berghoff
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 5/8/2025 doi:10.1002/cac2.70031
LETTER TO THE JOURNAL
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study
Niels Heersche, Daan A. C. Lanser, Esther Oomen-de Hoop, Attila I?li, Peter de Bruijn, Marthe S. Paats, Elisabeth F. C. van Rossum, Stijn L. W. Koolen, Ron H. N. van Schaik, Anne-Marie C. Dingemans, G. D. Marijn Veerman, Ron H. J. Mathijssen
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 5/1/2025 doi:10.1002/cac2.70030
REVIEW
Neutrophils in cancer: At the crucial crossroads of anti-tumor and pro-tumor
Wenpeng Cai, Tao Fan, Chu Xiao, Ziqin Deng, Yixiao Liu, Chunxiang Li, Jie He
Cancer Communications 2025 45: [Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/29/2025 doi:10.1002/cac2.70027
LETTER TO THE JOURNAL
Risk of colorectal cancer and cancer-related mortality in type 2 diabetes patients treated with metformin, SGLT-2 inhibitors, or their combination
Xianhua Mao, Ka-Shing Cheung, Jing-Tong Tan, Lung-Yi Mak, Chi-Ho Lee, Ho Ming Cheng, Rex Wan-Hin Hui, Esther Wai Yin Chan, Philip Leung-Ho Yu, Man-Fung Yuen, Wai K Leung, Wai-Kay Seto
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/24/2025 doi:10.1002/cac2.70028
ORIGINAL ARTICLE
Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2-mediated increase of SOAT2 RNA methylation
Jinhua Jiang, Feng Liu, Dan Cui, Caixia Xu, Jiachang Chi, Tinghua Yan, Fang Guo
Cancer Communications 2025 45: [Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/14/2025 doi:10.1002/cac2.70023
LETTER TO THE JOURNAL
Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial
Kyoungmin Lee, Kyung-Hun Lee, Dong-Wan Kim, Jeesun Yoon, Yoon Ji Choi, Soohyeon Lee, Ju Won Kim, Kyong Hwa Park, Wonyoung Choi, Youngjoo Lee, Hyewon Ryu, Dong-Hoe Koo, YunGyoo Lee, Hei-Cheul Jeung, Min-Young Lee, Namsu Lee, Myoung Joo Kang, Jieun Lee, Sook Hee Hong, Eun Joo Kang, In Hae Park
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/11/2025 doi:10.1002/cac2.70026
REVIEW
Combating cancer immunotherapy resistance: a nano-medicine perspective
Xiangyi Kong, Xintong Xie, Juan Wu, Xiangyu Wang, Wenxiang Zhang, Shuowen Wang, Daria Valerievna Abbasova, Yi Fang, Hongnan Jiang, Jidong Gao, Jing Wang
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/10/2025 doi:10.1002/cac2.70025
ORIGINAL ARTICLE
Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL-1β and the inflammasome pathway
Xuejiao Han, Yuan Cheng, Dandan Wan, Aqu Alu, Ziqi Zhang, Zhenfei Bi, Manni Wang, Yan Tang, Weiqi Hong, Siyuan Chen, Li Chen, Yuquan Wei
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/10/2025 doi:10.1002/cac2.70024
LETTER TO THE JOURNAL
Deciphering the transcriptomic landscape of early HR+/HER2- breast cancer in very young women
Iris Garrido-Cano, Marta Tapia, Juan Carbonell, Carlos Pe?a, Sandra Torres-Ruiz, Anna ágreda-Roca, Ana Lameirinhas, Cristina Tebar, Octavio Burgués, Cristina Hernando, Ana Lluch, Fara Brasó-Maristany, Aleix Prat, Bego?a Bermejo, María Teresa Martínez, Juan Miguel Cejalvo
Cancer Communications 2025 45: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 4/10/2025 doi:10.1002/cac2.70019
ORIGINAL ARTICLE
Global trends and epidemiological shifts in gastrointestinal cancers: insights from the past four decades
Mengmeng Li, Sumei Cao, Rui-Hua Xu
Cancer Communications 2025 45: [Abstract ] [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 3/28/2025 doi:10.1002/cac2.70017
